Get the app!
Back to Trades

Ignelzi Troy A.

DirectorCIK 0001579829

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Ignelzi Troy A., Director, has filed 1 SEC report (2026), all concentrated in Contineum Therapeutics, Inc. (CTNM), totaling $269.6K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Jun 26CTNM
Contineum Therapeutics, Inc.
Ignelzi Troy A.DirectorAward$269.6K

1 filing